Estimation of Nitric Oxide, Malondialdehyde, and Adenosine Deaminase in Serum of Hypertensive Patients and Normotensive Individuals in Erbil City

Article Sidebar

pdf
Published: May 9, 2019
DOI: https://doi.org/10.25130/tjps.v24i3.364
Keywords:
Oxidative stress, hypertension, nitric oxide, MDA, adenosine deaminase

Main Article Content

Gulzar I. Ibrahim
Saman M. Abdulkareem
Lutfiya M. Hasan

Abstract

This study was aimed to estimate nitric oxide (NO), malondialdehyde (MDA), and adenosine deaminase (ADA) in the serum of hypertensive patients. Fifty patients (25 males and 25 females) age 40-70 diagnosed with hypertension involved in the study. Fifty healthy individuals, who had no hypertension in the last year, were identified as the control group. NO, MDA and ADA have performed accordingly. MDA was higher with aging and gender in hypertensive patients. Serum level of MDA was higher in females compared with male due to oxidative stress more in female than a male with aging. ADA was higher among hypertensive with aging, though no significant differences among gender. Serum level of NO was lower with aging with no significant differences among gender.

Article Details

How to Cite
Gulzar I. Ibrahim, Saman M. Abdulkareem, & Lutfiya M. Hasan. (2019). Estimation of Nitric Oxide, Malondialdehyde, and Adenosine Deaminase in Serum of Hypertensive Patients and Normotensive Individuals in Erbil City. Tikrit Journal of Pure Science, 24(3), 17–22. https://doi.org/10.25130/tjps.v24i3.364
Issue
Vol. 24 No. 3 (2019)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.

References

[1] WHO, W. (2009). Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization.

[2] Chow, C.K. et al. (2013). Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. Jama, 310 (9):959-968.

[3] Behradmanesh, S.;Derees, F. andRafieian-Kopaei, M. (2013). Effect of Salvia officinalis on diabetic patients. Journal of renal injury prevention, 2(2):51-54.

[4] Pedro-Botet, J.;Covas, M.; Martin, S. and Rubies-Prat, J. (2000). Decreased endogenous antioxidant enzymatic status in essential hypertension. Journal of human hypertension, 14(6):343-345.

[5] Touyz, R.M. and Briones, A.M. (2011). Reactive oxygen species and vascular biology: implications in human hypertension. Hypertension research, 34(1):5-14.

[6] Grossman, E. (2008). Does increased oxidative stress cause hypertension? Diabetes Care, 31(2):185-S189.

[7] Coats, A. and Jain, S. (2017). Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage. Journal of human hypertension, 31(6):376-381.

[8] Michel, J.B.; Feron, O.; Sase, K.; Prabhakar, P. and Michel, T. (1997). Caveolin versus calmodulin counterbalancing allosteric modulators of endothelial nitric oxide synthase. Journal of Biological Chemistry, 272(41):25907-25912.

[9] El-Beltagi, H.S. and Mohamed, H.I. (2013). Reactive oxygen species, lipid peroxidation, and antioxidative defense mechanism. Notulae Botanicae Horti Agrobotanici Cluj-Napoca, 41(1):44-57.

[10] Zieba, M. et al. (2001). Enhanced lipid peroxidation in cancer tissue homogenates in non-small cell lung cancer. Monaldi archives for chest disease, 56(2):110-114.

[11] Ahmad, A.; Hossain, M.M.; Singhal, U. and Islam, N. (2013). Comparative study of marker of oxidative stress among normotensive, pre-hypertensive and hypertensive subjects. Biomedical Research, 24(4):493-497.

[12] Kalairanam, K.;Dharmalingam, M. and Marcus, S.R. (2006). Lipid peroxidation in type 2 diabetes mellitus. Int J Diab Dev Ctries, 26:30-32.

[13] Rai, R.R. andPhadke, M.S. (2006). Plasma oxidant-antioxidant status in different respiratory disorders. IndianJournal of Clinical Biochemistry, 21(2):161-164.

[14] Livrea, M. et al. (1996). Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood, 88(9):3608-3614.

[15] Kumar, A.;Sivakanesan, R. andGunasekera, S. (2008). Antioxidants, oxidative stress status and waist/hip ratio in normolipidaemic AMI patients. Pakistan Journal of Medical Sciences, 24(5):689-693.

[16] Hristozov, D.; Gadjeva, V.; Vlaykova, T. and Dimitrov, G. (2001). Evaluation of oxidative stress in patients with cancer. Archives of physiology and biochemistry, 109(4):331-336.

[17] Prakash, M.S. et al. (2006). Altered adenosine deaminase activity in type 2 diabetes mellitus. Journal, Indian Academy of Clinical Medicine, 7(2):114-117.

[18] Lamers, D. et al. (2011). Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes, 60(7):1917-1925.

[19] Jadhav, A.A. and Jain, A. (2012). Elevated adenosine deaminase activity in overweight and obese Indian subjects. Archives of Physiology and Biochemistry, 118(1):1-5.

[20] Miranda, K.M.;Espey, M.G. and Wink, D.A. (2001). A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric oxide, 5(1):62-71.

[21] Ghasemi, A.;Hedayati, M. and Biabani, H. (2007). Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess assay. JMSR, 2:29-32.

[22] Bhutia, Y.; Ghosh, A.; Sherpa, M. L.; Pal, R. and Mohanta, P.K. (2011). Serum malondialdehyde level: Surrogate stress marker in the Sikkimese diabetics. Journal of natural science, biology, and medicine, 2(1):107-112.

[23] Ninghot, A.;Mohod, K. and Kumar, S. (2017). Evaluation of Serum Adenosine Deaminase (ADA) Values for Detection of Pulmonary and Extra-pulmonary Tuberculosis. International Journal of Clinical Biochemistry and Research, 4(2):106-110.

[24] Hashemi, M.; Tehrani, F.K.; Ghavami, S. and Sabet, M.S. (2005). Adenosine Deaminase activity in Estrogen receptor positive and negative human breast cancer cell lines. Medical Journal of The Islamic Republic of Iran (MJIRI), 19(1):53-56.

[25] Yildirim, B.; Demir, S.;Temur, L.; Erdemir, R. and Kaleli, B.(2007). Lipid peroxidation in follicular fluid of women with polycystic ovary syndrome. Journal of Reproductive Medicine, 52(8):722-726.

[26] Bednarek-Tupikowska, G., et al. (2001). Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women. Gynecological Endocrinology, 15 (4):298-303.

[27] Simic, D. et al. (2006). Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. Journal of human hypertension, 20 (2):149-155.

[28] Singh, P.; Verma, M.K.; Tripathi, P. and Singh, D. (2016). Study of oxidant (MDA) and antioxidants (SOD and Vitamin E) in hypertensive patients and

normotensive individuals. International Journal of Life-Sciences Scientific Research, 2 (1):9-14.

[29] Vijaya, B.M.;Prashakara, R.P. andBalu, M.K. (2015). Correlative association of interleukin-6 with malondialdehyde in prehypertensive and hypertensive subjects. Journal of Dental and Medical Sciences, 14(7):53-7.

[30] Crowley, S.D. (2014). The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxidants and Redox Signaling. 20(1):102-120.

[31] Ghasemi, A.; Asl, S.Z.; Mehrabi, Y.; Saadat, N. and Azizi, F. (2008). Serum nitric oxide metabolite levels in a general healthy population: relation to sex and age. Life sciences, 83(9-10):326-331.

[32] Chen, Z.and Niki, E. (2011). Two faces of lipid peroxidation products: The Yin and Yang principles of oxidative stress. J Experimental and Integrative Medicine,1(4):215-219.

[33] Dauqan, E.M.A.; Abdullah, A. and Sani, H.A. (2011). Natural antioxidants, lipid profile, lipid peroxidation, antioxidant enzymes of different vegetable oils. Advance Journal of Food Science and Technology,3(4):308-316.

[34] Node, K.; Kitakaze, M.; Yoshikawa, H.; Kosaka, H. and Hori, M. (1997). Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension, 30 (3):405-408.

[35] Cardillo, C. and Panza, J.A. (1998). Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension. Vascular Medicine, 3 (2):138-144.

[36] Sharma, S.K. et al. (2001). A prospective study of sensitivity and specificity of adenosine deaminase estimation in the diagnosis of tuberculosis pleural effusion. The Indian journal of chest diseases & allied sciences, 43 (3):149-55.

[37] Mishra, O.P.; Garg, R. and Ali, Z. (1997). Adenosine deaminase activity in nephrotic syndrome. Journal of tropical pediatrics, 43(1):33-37.

[38] Köse, K.; Yazici, C. and Aşçioğlu, Ö. (2001). The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet’s disease. Clinical biochemistry, 34(2):125-129.

[39] Ungerer, J.P.; Oosthuizen, H.M.;Bissbort, S.H. and Vermaak, W.J. (1992). Serum adenosine deaminase: isoenzymes and diagnostic application. Clinical Chemistry, 38(7):1322-1326.

[40] Sajjan, N.B. and Makandar, A. (2016). Evaluation of serum adenosine deaminase levels with components of metabolic syndrome. International Journal of Clinical Biochemistry and Research, 3 (2):285-291.